NL8200489A - Op de 10-plaats met een onverzadigde groep gesubstitueerde derivaten van de 1,8-dihydroxy-9-anthronreeks, alsmede de toepassing ervan in farmaceutische preparaten voor mens of dier en in cosmetische preparaten. - Google Patents
Op de 10-plaats met een onverzadigde groep gesubstitueerde derivaten van de 1,8-dihydroxy-9-anthronreeks, alsmede de toepassing ervan in farmaceutische preparaten voor mens of dier en in cosmetische preparaten. Download PDFInfo
- Publication number
- NL8200489A NL8200489A NL8200489A NL8200489A NL8200489A NL 8200489 A NL8200489 A NL 8200489A NL 8200489 A NL8200489 A NL 8200489A NL 8200489 A NL8200489 A NL 8200489A NL 8200489 A NL8200489 A NL 8200489A
- Authority
- NL
- Netherlands
- Prior art keywords
- anthron
- dihydroxy
- maleate
- ylidene
- group
- Prior art date
Links
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical class C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 title claims description 54
- 238000002360 preparation method Methods 0.000 title claims description 25
- 239000002537 cosmetic Substances 0.000 title claims description 6
- 241001465754 Metazoa Species 0.000 title description 5
- 239000000825 pharmaceutical preparation Substances 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims description 50
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 32
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 32
- -1 dipropyl (1,8-dihydroxy-9-anthron) Chemical compound 0.000 claims description 22
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 17
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 13
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 201000004681 Psoriasis Diseases 0.000 claims description 6
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 239000011976 maleic acid Substances 0.000 claims description 3
- OYYKSLWYDCLNIT-UHFFFAOYSA-N 2,3-dibenzyl-1,8-dihydroxy-10H-anthracen-9-one Chemical compound C(C1=CC=CC=C1)C=1C(=C(C=2C(C3=C(C=CC=C3CC=2C=1)O)=O)O)CC1=CC=CC=C1 OYYKSLWYDCLNIT-UHFFFAOYSA-N 0.000 claims description 2
- QHKOKUFJUIYNNL-UHFFFAOYSA-N 2,3-diethyl-1,8-dihydroxy-10H-anthracen-9-one Chemical compound C(C)C=1C(=C(C=2C(C3=C(C=CC=C3CC=2C=1)O)=O)O)CC QHKOKUFJUIYNNL-UHFFFAOYSA-N 0.000 claims description 2
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 claims description 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 239000003581 cosmetic carrier Substances 0.000 claims description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 10
- 235000019260 propionic acid Nutrition 0.000 claims 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 4
- UWNADWZGEHDQAB-UHFFFAOYSA-N 2,5-dimethylhexane Chemical group CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 claims 2
- DLRVAHCNVVWDMI-UHFFFAOYSA-N 2-butyl-1,8-dihydroxy-10h-anthracen-9-one Chemical compound C1=CC(O)=C2C(=O)C3=C(O)C(CCCC)=CC=C3CC2=C1 DLRVAHCNVVWDMI-UHFFFAOYSA-N 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- ROXDJNYYEVZKBA-UHFFFAOYSA-N 1,8-dihydroxy-2-methyl-10h-anthracen-9-one Chemical compound C1=CC(O)=C2C(=O)C3=C(O)C(C)=CC=C3CC2=C1 ROXDJNYYEVZKBA-UHFFFAOYSA-N 0.000 claims 1
- FIHZWZBEAXASKA-UHFFFAOYSA-N Anthron Natural products COc1cc2Cc3cc(C)cc(O)c3C(=O)c2c(O)c1C=CC(C)C FIHZWZBEAXASKA-UHFFFAOYSA-N 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- MAWOHFOSAIXURX-UHFFFAOYSA-N cyclopentylcyclopentane Chemical group C1CCCC1C1CCCC1 MAWOHFOSAIXURX-UHFFFAOYSA-N 0.000 claims 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical group CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 39
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 32
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 239000012298 atmosphere Substances 0.000 description 10
- 230000007717 exclusion Effects 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 229960002311 dithranol Drugs 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- 238000010828 elution Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000012300 argon atmosphere Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 description 1
- JPHOVQDWZXAXPU-UHFFFAOYSA-N 3-bromo-3-hydroxyoxolane-2,5-dione Chemical compound BrC1(C(=O)OC(C1)=O)O JPHOVQDWZXAXPU-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N Acetylene Chemical class C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical class C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 235000010044 Hernandia moerenhoutiana Nutrition 0.000 description 1
- 244000084296 Hernandia moerenhoutiana Species 0.000 description 1
- JLNTWVDSQRNWFU-UHFFFAOYSA-N OOOOOOO Chemical compound OOOOOOO JLNTWVDSQRNWFU-UHFFFAOYSA-N 0.000 description 1
- HFEFMUSTGZNOPY-UHFFFAOYSA-N OOOOOOOOOOOOOOOO Chemical compound OOOOOOOOOOOOOOOO HFEFMUSTGZNOPY-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940030999 antipsoriatics Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- IMAKHNTVDGLIRY-UHFFFAOYSA-N methyl prop-2-ynoate Chemical compound COC(=O)C#C IMAKHNTVDGLIRY-UHFFFAOYSA-N 0.000 description 1
- LSCYTCMNCWMCQE-UHFFFAOYSA-N n-methylpyridin-4-amine Chemical compound CNC1=CC=NC=C1 LSCYTCMNCWMCQE-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000001149 thermolysis Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8102572A FR2499556B1 (enExample) | 1981-02-10 | 1981-02-10 | |
| FR8102572 | 1981-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8200489A true NL8200489A (nl) | 1982-09-01 |
Family
ID=9255021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8200489A NL8200489A (nl) | 1981-02-10 | 1982-02-09 | Op de 10-plaats met een onverzadigde groep gesubstitueerde derivaten van de 1,8-dihydroxy-9-anthronreeks, alsmede de toepassing ervan in farmaceutische preparaten voor mens of dier en in cosmetische preparaten. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4464301A (enExample) |
| JP (1) | JPS57149249A (enExample) |
| BE (1) | BE892076A (enExample) |
| CA (1) | CA1207762A (enExample) |
| CH (1) | CH651290A5 (enExample) |
| DE (1) | DE3204446A1 (enExample) |
| FR (1) | FR2499556B1 (enExample) |
| GB (1) | GB2092588B (enExample) |
| IT (1) | IT1157920B (enExample) |
| NL (1) | NL8200489A (enExample) |
| SE (1) | SE437659B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4843097A (en) * | 1984-06-13 | 1989-06-27 | Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. | 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics |
| US5426197A (en) * | 1993-07-19 | 1995-06-20 | Teva Pharmaceutical Industries, Ltd. | 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1013901A (en) * | 1962-01-26 | 1965-12-22 | Kefalas As | Dihydroanthracene, dibenzocycloheptadiene and dibenzocycloheptatriene derivatives |
| NL299449A (enExample) * | 1962-10-19 | |||
| US3502697A (en) * | 1967-01-03 | 1970-03-24 | Pfizer & Co C | Antibacterial agents |
| FI57743C (fi) * | 1979-03-29 | 1980-10-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av nya 1,8-dihydroxi-10-acyl-9-antroner mot psoriasis |
| FR2492372A1 (fr) * | 1980-10-21 | 1982-04-23 | Cird | Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
-
1981
- 1981-02-10 FR FR8102572A patent/FR2499556B1/fr not_active Expired
-
1982
- 1982-02-08 US US06/346,893 patent/US4464301A/en not_active Expired - Fee Related
- 1982-02-09 DE DE19823204446 patent/DE3204446A1/de not_active Ceased
- 1982-02-09 IT IT19539/82A patent/IT1157920B/it active
- 1982-02-09 GB GB8203673A patent/GB2092588B/en not_active Expired
- 1982-02-09 CA CA000395818A patent/CA1207762A/fr not_active Expired
- 1982-02-09 CH CH825/82A patent/CH651290A5/fr not_active IP Right Cessation
- 1982-02-09 JP JP57018295A patent/JPS57149249A/ja active Pending
- 1982-02-09 SE SE8200745A patent/SE437659B/sv not_active IP Right Cessation
- 1982-02-09 NL NL8200489A patent/NL8200489A/nl not_active Application Discontinuation
- 1982-02-09 BE BE0/207268A patent/BE892076A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH651290A5 (fr) | 1985-09-13 |
| SE437659B (sv) | 1985-03-11 |
| US4464301A (en) | 1984-08-07 |
| DE3204446A1 (de) | 1982-09-02 |
| BE892076A (fr) | 1982-08-09 |
| GB2092588B (en) | 1984-08-22 |
| FR2499556B1 (enExample) | 1983-03-25 |
| IT1157920B (it) | 1987-02-18 |
| GB2092588A (en) | 1982-08-18 |
| IT8219539A0 (it) | 1982-02-09 |
| SE8200745L (sv) | 1982-08-11 |
| JPS57149249A (en) | 1982-09-14 |
| FR2499556A1 (enExample) | 1982-08-13 |
| CA1207762A (fr) | 1986-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2543099C2 (de) | 2-Phenylbenzofurane enthaltende kosmetische Sonnenschutzmittel, Verfahren zur Herstellung von 2-Phenylbenzofuranen und 2-Phenylbenzofurane als solche | |
| RU2065864C1 (ru) | Производные глицирретовой кислоты и способ их получения | |
| Venkataiah et al. | Charminarone, a seco-pseudoguaianolide from Parthenium hysterophorus | |
| NL8104718A (nl) | 4,5-polymethyleen-4-isothiazolin-3-onen, werkwijze ter bereiding daarvan alsmede toepassing daarvan als bactericiden en fungiciden. | |
| Spinella et al. | New 3-alkylpyridines from three Mediterranean cephalaspidean molluscs: structure, ecological role and taxonomic relevance | |
| NL8200489A (nl) | Op de 10-plaats met een onverzadigde groep gesubstitueerde derivaten van de 1,8-dihydroxy-9-anthronreeks, alsmede de toepassing ervan in farmaceutische preparaten voor mens of dier en in cosmetische preparaten. | |
| NL7907982A (nl) | Werkwijze ter bereiding van hoog-smeltend chenodeoxycholzuur. | |
| CA2106758A1 (fr) | Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant | |
| KR100503631B1 (ko) | 레티놀 유도체 및 그의 제조방법 | |
| NL193317C (nl) | 1,8-Diacyloxy-10-acylantronen en cosmetische en farmaceutische samenstellingen die ze bevatten. | |
| SU680650A3 (ru) | Способ получени 7 - 2-амино-2-(3-метилсульфониламинофенил)-ацетиламино-3-хлор-3-цефем-4-карбоновой кислоты или ее солей | |
| DE2633690A1 (de) | Verfahren zur selektiven veresterung der primaeren alkoholfunktionen von diholosiden, die dabei erhaltenen produkte und ihre therapeutische verwendung | |
| US7119238B2 (en) | Process for purification and crystallization of palm oil carotenoids | |
| EP0388314B1 (fr) | Esters rétinoiques de l-cladinose, leur procédé de préparation et leur utilisation en médecine humaine ou vétérinaire et en cosmétique | |
| DE2033959A1 (de) | Verfahren zur Herstellung von neuen Aryloxy und Arylthioessigsauredenvaten | |
| DE2128605A1 (de) | Neue Cephalosporansäurederivaten und Verfahren zu ihrer Herstellung | |
| DE1804983A1 (de) | Verfahren zur Herstellung von Cephalosporansaeurederivaten | |
| DE3612861A1 (de) | 1-hydroxy-8-acyloxy-10-acylanthrone, verfahren zu deren hersellung und diese verbindungen enthaltende kosmetische und pharmazeutische mittel | |
| US4558069A (en) | 1,8-Dihydroxy-9-anthrones derivatives substituted in the 10-position by an unsaturated radical used in human medicine | |
| US3325359A (en) | Antibiotic factor s and compositions containing same | |
| JPS5946224A (ja) | 麦から得られる降圧成分ならびにその採取法 | |
| Asato et al. | The synthesis of 3-n-hexyldithiacycloheptan-5-one, a novel cyclic ketodisulfide from dictyopteris | |
| Sanchez et al. | Tandem addition–cyclization mediated by sulfanyl radicals: a versatile strategy for iridoids synthesis | |
| Csákÿ et al. | Asymmetric CC bond formation by the mixed oxidative coupling of 1, 1′-bi-2-naphthyl esters | |
| CA2012219C (fr) | Esters retinoiques de d-desosamine, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BV | The patent application has lapsed | ||
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |